Inflammation‑based prognostic markers in patients with advanced or recurrent gastric cancer treated with nivolumab: Tokushukai REAl‑world Data project 02 (TREAD 02)
Rai Shimoyama(Fukuoka Tokushukai Hospital), Hironobu Minami(Kobe University), Kiyoaki Uryu(Yao Tokushukai General Hospital), Megumi Shiragami(Fukuoka Tokushukai Hospital), Maki Hayashi(Mirai Hospital), Keiko Ohtani, T. Mase, Nobuaki Shinozaki(Fukuoka Tokushukai Hospital), Yoshiaki Fujimura(Fukuoka Tokushukai Hospital), Megu Ohtaki(Hiroshima University), Yoshinori Imamura(Kobe University)
Cited by 6
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
|Oncology Reports|2015|852
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|Annals of Oncology|2017|591
Apparent Diffusion Coefficient of Human Brain Tumors at MR Imaging
|Radiology|2005|505
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464